A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line...
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Dr Simon Erridge reflects on some of the key findings published on medical cannabis this year.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line...
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains,...
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed....
A new review highlights significant gaps in the evidence for medical cannabis, but other researchers say it may not present a balanced picture.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new...
